CHEN; Weichun

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHEN; Weichun.The latest application filed is for "process for the preparation of (6s)-3-[(4s)-4-cyano-2-oxo-pyrrolidin-1-yl]-6-methyl-n-(3,4,5-trifluoroph- enyl)-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine-5-carboxamide".

Company Profile

3.4.15

CHEN; Weichun - Shanghai CN
Chen; Weichun - Livingston NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process For The Preparation Of (6s)-3-[(4s)-4-cyano-2-oxo-pyrrolidin-1-yl]-6-methyl-n-(3,4,5-trifluoroph- Enyl)-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine-5-carboxamide App 20220162212 - CHEN; Weichun ; et al.	2022-05-26
Process For The Preparation Of Tetrahydropyridopyrimidines App 20220098189 - CHEN; Junli ; et al.	2022-03-31
Process For The Preparation Of Exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamate App 20220073469 - CHEN; Weichun ; et al.	2022-03-10
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors Grant 10,336,719 - Chen , et al.	2019-07-02
Novel Compounds App 20190010135 - Chen; Weichun ; et al.	2019-01-10
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors Grant 10,106,515 - Chen , et al. October 23, 2	2018-10-23
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea Derivatives As Cxcr2 Inhibitors App 20170190681 - CHEN; Weichun ; et al.	2017-07-06
Quinazolinone Derivatives Useful As Vanilloid Antagonists App 20130060029 - Chen; Weichun ; et al.	2013-03-07
Quinazolinone derivatives useful as vanilloid antagonists Grant 8,349,852 - Chen , et al. January 8, 2	2013-01-08
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20120178750 - Raghavan; Subharekha ; et al.	2012-07-12
Niacin receptor agonists, compositions containing such compounds and methods of treatment Grant 8,168,649 - Raghavan , et al. May 1, 2	2012-05-01
Quinazolinone Derivatives Useful as Vanilloid Antagonists App 20100197705 - Chen; Weichun ; et al.	2010-08-05
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20100144778 - Raghavan; Subharekha ; et al.	2010-06-10
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20090170891 - Colletti; Steven L. ; et al.	2009-07-02
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20090042926 - Imbriglio; Jason ; et al.	2009-02-12
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20070299101 - Colletti; Steven L. ; et al.	2007-12-27
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment App 20070281969 - Colletti; Steven L. ; et al.	2007-12-06
Niacin receptor agonists, compositions containing such compounds and methods of treatment App 20060293364 - Raghavan; Subharekha ; et al.	2006-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.